HDAC9 and cervical adenocarcinoma: We therefore conducted a comprehensive investigation of the effects of statins on HDAC activity in both live cells and nuclear extracts, using a variety of different cell lines, including HepG2 hepatocellular carcinoma cells, MDA-MB-231 breast carcinoma cells, and HeLa cervical adenocarcinoma extracts.